Association of follicle-stimulating hormone receptor gene polymorphism with the outcomes of assisted reproductive technology programs
- Autores: Vladimirova I.V1, Kalinina E.A1, Donnikov A.E1
-
Afiliações:
- Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Edição: Nº 8 (2014)
- Páginas: 53-58
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247251
- ID: 247251
Citar
Texto integral
![Acesso aberto](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Texto integral
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
I. Vladimirova
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: i_teterina@oparina4.ru
postgraduate of the Department of assistive reproductive technology in the treatment of infertility
E. Kalinina
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: e_kalinina@oparina4.ru
M.D., Ph.D., Head of the Department of assistive reproductive technology in the treatment of infertility
A. Donnikov
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: a_donnikov@oparina4.ru
PhD, senior staff scientist of laboratory of molecular genetic methods
Bibliografia
- Falconer H., Andersson E., Aanesen A., Fried G. Follicle-stimulating hormone receptor polymorphisms in a population of infertile women. Acta Obstet. Gynecol. Scand. 2005; 84(8): 806-11.
- Yao Y., Ma C.H., Tang H.L., Hu Y.F. Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Mol. Genet. Metab. 2011; 103(4): 388-93.
- Huber M., Hadziosmanovic N., Berglund L., Holte J. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem. Fertil. Steril. 2013; 100(5): 1270-6.
- Ferraretti A P., La Marca A., Fauser B.C., Tarlatzis B., Nargund G., Gianaroli L. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum. Reprod. 2011; 26(7): 1616-24.
- Polyzos N.P., Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil. Steril. 2011; 96(5): 1058-61. e1057.
- Назаренко Т.А., Краснопольская К.В. “Бедный ответ”. Тактика ведения пациенток со сниженной реакцией на стимуляцию гонадотропинами в программах ЭКО. 2-е изд. М.: МЕДпресс-информ; 2013. 80 c. [Nazarenko T.A., Krasnopolskaya K.V. “Poor response”. Clinical management of patients with a reduced response to gonadotropin stimulation in IVF programs. 2nd ed. M.: MEDpress Inform; 2013. 80 c.]
- American Society of Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil. Steril. 2008; 90(5, Suppl.): S188-93.
- Delvigne A. Symposium: Update on prediction and management of OHSS. Epidemiology of OHSS. Reprod. Biomed. Online. 2009; 19(1): 8-13.
- Сухих Г.Т., Назаренко Т.А., ред. Бесплодный брак. Современные подходы к диагностике и лечению. 2-е изд. М.: ГЭОТАР-Медиа; 2010. 784 c. [Sukhikh G.T., Nazarenko T.A., eds. Sterile marriage. Current approaches to diagnosis and treatment. 2nd ed. M.: GEOTAR Media; 2010. 784 c.]
- Калинина Е.А., Эбзеева М.В., Кузьмичев Л.Н. Опыт применения “мягких” схем стимуляции суперовуляции у пациенток группы риска развития синдрома гиперстимуляции яичников. Акушерство и гинекология. 2010, 6: 60-4. [Kalinina E.A., Ebzeyeva M.V., Kuzmichev L.N. Experience with mild superovulation regimens used in ovarian hyperstimulation syndrome risk group patients. Obstetrics and Gynecology. 2010, 6: 60-4.]
- Altmae S., Hovatta O., Stavreus-Evers A., Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum. Reprod. Update. 2011; 17(6): 813-28.
- Desai S.S., Achrekar S.K., Paranjape S.R., Desai S.K., Mangoli V.S., Mahale S.D. Association of allelic combinations of FSHR gene polymorphisms with ovarian response. Reprod. Biomed. Online. 2013; 27(4): 400-6.
- Greb R.R., Behre H.M., Simoni M. Pharmacogenetics in ovarian stimulation - current concepts and future options. Reprod. Biomed. Online. 2005; 11(5): 589-600.
- Laan M., Grigorova M., Huhtaniemi I.T. Pharmacogenetics of follicle-stimulating hormone action. Curr. Opin. Endocrinol. Diabet. Obes. 2012; 19(3): 220-7.
- Perez Mayorga M., Gromoll J., Behre H.M., Gassner C., Nieschlag E., Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J. Clin. Endocrinol. Metab. 2000; 85(9): 3365-9.
- Элдер К., Дэйл Б. Экстракорпоральное оплодотворение: пер. с англ. М.: МЕДпресс-информ; 2008. 276 c.[Elder K., Dale B. In vitro fertilization: trans. from English. M.: MEDpress Inform; 2008. 276 c.]
- Moron F.J., Ruiz A. Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers. Pharmacogenomics. 2010; 11(11): 1613-8.
- La Marca A., Sighinolfi G., Argento C., Grisendi V., Casarini L., Volpe A., Simoni M. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization. Fertil. Steril. 2013; 99(4): 970-8. e971.
- Баранов В.С., ред. Генетический паспорт - основа индивидуальной и предиктивной медицины. СПб.: Издательство Н-Л; 2009. 528 с. [Baranov V.S., eds. Genetic passport - the basis of individual and predictive medicine. St. Petersburg: Publisher N-L; 2009. 528 p.]
Arquivos suplementares
![](/img/style/loading.gif)